Search Within

Vicky Makker

Formats
  1. Meeting Abstract (140)
  2. Journal Article (110)
  3. Review (9)
  4. Editorial (3)
  5. Book Section (2)
  6. Guidelines (1)
Groups
  1. Department of Medicine (265)
  2. GDMT, Medicine (265)
  3. Gynecologic Medicine Service (265)
  4. Gynecology Disease Management Team (265)
  5. Solid Tumor Oncology Division (265)
  6. Surgery (94)

More Groups

People
  1. Carol Aghajanian (91)
  2. Nadeem Abu-Rustum (77)
  3. Mario Leitao (49)
  4. Alexia Iasonos (47)
  5. Kaled Alektiar (45)
  6. Qin Zhou (43)

More People

Years
  1. 2025 (9)
  2. 2024 (35)
  3. 2023 (39)
  4. 2022 (36)
  5. 2021 (19)
  6. 2020 (26)

More Years

Publications
  1. Gynecologic Oncology (65)
  2. Journal of Clinical Oncology (58)
  3. International Journal of Gynecological Cancer (34)
  4. Annals of Oncology (23)
  5. Gynecologic Oncology Reports (8)
  6. Clinical Cancer Research (6)

More Publications

Publishers
  1. Elsevier Inc. (74)
  2. American Society of Clinical Oncology (61)
  3. Lippincott Williams & Wilkins (35)
  4. Oxford University Press (26)
  5. American Association for Cancer Research (12)
  6. Wiley Blackwell (9)

More Publishers

Results (265)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase II study of rucaparib and nivolumab in patients with leiomyosarcoma
    Journal Article

    Movva, S.; Seier, K.; Bradic, M.; Charalambous, K.; Rosenbaum, E.; Kelly, C. M.; Cohen, S. M.; Hensley, M. L.; Avutu, V.; Banks, L. B.; more...
    Journal for ImmunoTherapy of Cancer (2025)

    Fulltext@MSK | Save
  • A phase II study of fulvestrant plus abemaciclib in hormone receptor–positive advanced or recurrent endometrial cancer
    Journal Article

    Green, A. K.; Zhou, Q.; Iasonos, A.; Zammarrelli, W. A. 3rd; Weigelt, B.; Ellenson, L. H.; Chhetri-Long, R.; Shah, P.; Loh, J.; Hom, V.; more...
    Clinical Cancer Research (2025)

    Fulltext@MSK | Save
  • Effect of substantial lymphovascular space invasion on location of first disease recurrence in surgical stage I endometrioid endometrial adenocarcinoma
    Journal Article

    Dagher, C.; Bjerre Trent, P.; Alwaqfi, R.; Davidson, B.; Ellenson, L. H.; Zhou, Q.; Iasonos, A.; Mueller, J. J.; Alektiar, K.; Makker, V.; more...
    International Journal of Gynecological Cancer (2025)

    Fulltext@MSK | Save
  • Summary of research: Efficacy of trastuzumab deruxtecan in HER2-expressing solid tumors by enrollment HER2 IHC status: Post hoc analysis of DESTINY-PanTumor02
    Journal Article

    Oaknin, A.; Lee, J. Y.; Makker, V.; Oh, D. Y.; Banerjee, S.; González-Martín, A.; Jung, K. H.; Ługowska, I.; Manso, L.; Manzano, A.; more...
    Advances in Therapy (2025)

    Fulltext@MSK | Save
  • TIP25-243: Randomized study evaluating optimal dose, efficacy and safety of E7386 + lenvatinib versus treatment of physicians' choice in advance/recurrent endometrial carcinoma previously treated with anti-PD-(L)1 immunotherapy
    Meeting Abstract

    Eskander, R.; Lee, J. Y.; Mirza, M.; Lorusso, D.; Mackay, H.; Ray-Coquard, I.; Oaknin, A.; Gonzalez-Martin, A.; Hasegawa, K.; Corr, B.; more...
    Journal of the National Comprehensive Cancer Network (2025)

    Fulltext@MSK | Save
  • First-line lenvatinib plus pembrolizumab versus chemotherapy for advanced endometrial cancer: A randomized, open-label, phase III trial
    Journal Article

    Marth, C.; Moore, R. G.; Bidzinski, M.; Pignata, S.; Ayhan, A.; Rubio, M. J.; Beiner, M.; Hall, M.; Vulsteke, C.; Braicu, E. I.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Patient outcomes in advanced ovarian cancer treated with an anti-FOLR1 antibody–drug conjugate
    Journal Article

    Johannet, P.; Flint, M.; Chui, M. H.; Konner, J.; Friedman, C.; Green, A. K.; Guo, R.; Hensley, M. L.; Kyi, C.; Liu, Y.; more...
    Gynecologic Oncology (2025)

    Fulltext@MSK | Save
  • The genomic landscape of distant metastatic endometrial cancer
    Journal Article

    Zammarrelli, W. A. 3rd; Nandakumar, S.; Kertowidjojo, E.; Nguyen, B.; Moukarzel, L. A.; Da Cruz Paula, A.; Rios-Doria, E. V.; Smith, S. A.; Momeni-Boroujeni, A.; Makker, V.; more...
    Gynecologic Oncology (2025)

    Fulltext@MSK | Save
  • Basket study of oral progesterone antagonist onapristone extended-release in combination with anastrozole in progesterone receptor-positive recurrent adult-type granulosa cell tumor of the ovary
    Journal Article

    Finch, L.; Andres, S.; Iasonos, A.; Zhou, Q.; Girshman, J.; Chhetri-Long, R.; Green, H.; Selenica, P.; Jang, D.; O'Cearbhaill, R. E.; more...
    International Journal of Gynecological Cancer (2025)

    Fulltext@MSK | Save
  • Dose-expansion part of a phase 1b global study of E7386 plus lenvatinib in patients with hepatocellular carcinoma and other solid tumors including endometrial cancer
    Meeting Abstract

    Lee, J. Y.; Ryoo, B. Y.; Kim, J. W.; Cheng, A. L.; Finn, R. S.; Hasegawa, K.; Makker, V.; Kudo, M.; Miller, D. S.; Merle, P.; more...
    International Journal of Gynecological Cancer (2024)

    Fulltext@MSK | Save